Invesco’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.07M Buy
219,795
+30,368
+16% +$425K ﹤0.01% 2406
2025
Q1
$2.58M Buy
189,427
+67,949
+56% +$924K ﹤0.01% 2435
2024
Q4
$2.48M Sell
121,478
-84,885
-41% -$1.73M ﹤0.01% 2527
2024
Q3
$6.01M Buy
206,363
+90,131
+78% +$2.63M ﹤0.01% 2113
2024
Q2
$2.7M Buy
116,232
+1,830
+2% +$42.5K ﹤0.01% 2463
2024
Q1
$2.35M Buy
114,402
+35,263
+45% +$724K ﹤0.01% 2577
2023
Q4
$1.7M Sell
79,139
-9,214
-10% -$198K ﹤0.01% 2672
2023
Q3
$1.82M Sell
88,353
-4,568
-5% -$94.2K ﹤0.01% 2634
2023
Q2
$2.74M Buy
92,921
+9,984
+12% +$295K ﹤0.01% 2524
2023
Q1
$1.91M Sell
82,937
-5,802
-7% -$134K ﹤0.01% 2647
2022
Q4
$2.47M Buy
88,739
+10,844
+14% +$302K ﹤0.01% 2553
2022
Q3
$2.39M Buy
77,895
+4,229
+6% +$130K ﹤0.01% 2554
2022
Q2
$2.17M Buy
73,666
+6,032
+9% +$178K ﹤0.01% 2663
2022
Q1
$2.18M Buy
67,634
+23,170
+52% +$745K ﹤0.01% 2733
2021
Q4
$1.98M Sell
44,464
-3,754
-8% -$167K ﹤0.01% 2783
2021
Q3
$2.43M Sell
48,218
-335,347
-87% -$16.9M ﹤0.01% 2715
2021
Q2
$30.1M Buy
383,565
+356,912
+1,339% +$28M 0.01% 1354
2021
Q1
$1.52M Sell
26,653
-185,922
-87% -$10.6M ﹤0.01% 2868
2020
Q4
$17.8M Sell
212,575
-101,824
-32% -$8.53M 0.01% 1494
2020
Q3
$11.3M Buy
314,399
+24,784
+9% +$888K ﹤0.01% 1602
2020
Q2
$7M Sell
289,615
-590
-0.2% -$14.3K ﹤0.01% 1817
2020
Q1
$5.08M Buy
290,205
+99,697
+52% +$1.75M ﹤0.01% 1871
2019
Q4
$3.32M Sell
190,508
-629
-0.3% -$11K ﹤0.01% 2395
2019
Q3
$2.93M Buy
191,137
+71,540
+60% +$1.1M ﹤0.01% 2423
2019
Q2
$2.48M Sell
119,597
-1,394
-1% -$28.9K ﹤0.01% 2582
2019
Q1
$2.81M Sell
120,991
-44,845
-27% -$1.04M ﹤0.01% 2392
2018
Q4
$3.43M Buy
165,836
+79,090
+91% +$1.63M ﹤0.01% 2182
2018
Q3
$1.89M Buy
+86,746
New +$1.89M ﹤0.01% 2789